Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    17698695 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Biological: BHT-3009-01

Study has passed its completion date and status has not been verified in more than two years.